Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer.
Sudo K, Ishihara T, Hirata N, Ozawa F, Ohshima T, Azemoto R, Shimura K, Nihei T, Nishino T, Nakagawa A, Nakamura K, Hara T, Tada M, Mikata R, Tawada K, Yokosuka O, Nakaji S, Yamaguchi T.
Sudo K, et al. Among authors: hara t.
Cancer Chemother Pharmacol. 2014 Feb;73(2):389-96. doi: 10.1007/s00280-013-2368-6. Epub 2013 Dec 10.
Cancer Chemother Pharmacol. 2014.
PMID: 24322377
Clinical Trial.